Meeting
2022 ASCO Genitourinary Cancers Symposium
Germline BRCA2, ATM and CHEK2 alterations shape somatic mutation landscapes in prostate cancer.
Authors
Mari Nakazawa
Johns Hopkins School of Medicine, Baltimore, MD
Mari Nakazawa , Mike Fang , Tamara L. Lotan , Jun Luo , William B. Isaacs , Channing Judith Paller , Emmanuel S. Antonarakis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 148)
DOI
10.1200/JCO.2022.40.6_suppl.148
Abstract #
148
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Clinical implications of molecular alterations in intraductal carcinoma of the prostate.
First Author: Benjamin Miron
Poster
2020 ASCO Virtual Scientific Program
Genomic landscape and immune phenotype of malignant pleural mesothelioma.
First Author: Meera Patel
Poster
2020 Genitourinary Cancers Symposium
Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Santosh Gupta
Poster
2018 ASCO Annual Meeting
Genomic profiling of primary prostate tumors from patients who develop metastatic castration-resistant prostate cancer (mCRPC).
First Author: Joaquin Mateo